Beyond The Printed Page

  1. A Pharma Exec Defines Her “Recipe for Business Success”
    3/18/2019

    Deborah Waterhouse, CEO of GSK’s joint venture ViiV Healthcare, discusses her three keys to business success.

  2. A CEO’s Most Formative Leadership Experience
    2/25/2019

    Intellia Therapeutics CEO, John Leonard, M.D., shares a formative leadership experience from his days at Abbott Laboratories. 

  3. What You Don’t Know About John Leonard, The CEO Of Intellia Therapeutics
    2/19/2019

    Intellia Therapeutics CEO, John Leonard, M.D., provides insight into why he entered industry, and his drive to be an entrepreneur. 

  4. Making A Difference Matters
    12/17/2018

    Dr. Helen Torley, president and CEO of Halozyme Therapeutics, shares a story of how the biopharmaceutical industry makes a difference.

  5. Helen Torley’s Path To The C-Suite
    12/12/2018

    Halozyme Therapeutics’ president and CEO, Dr. Helen Torley, discusses her path to the c-suite, including the formative experience that best prepared her for becoming a CEO.

  6. Could Halozyme’s U.S. Patent 8,846,034 Be Another Royalty Boon?
    12/10/2018

    Helen Torley, president and CEO of Halozyme Therapeutics, discusses hyaluronan and the role it plays in development of ENHANZE, PEGPH20 along with a staining diagnostic to determine patients with high levels of hyaluronic acid (HA).

  7. Insight For First-Time CEOs Presenting At JPM
    12/4/2018

    Halozyme Therapeutics’ president and CEO, Dr. Helen Torley, discusses her approach to preparing and presenting as a first-time CEO at the annual J.P. Morgan Healthcare Conference.

  8. Tech, Tax Cuts, Trump, & More — A Diversity Of Biopharma Perspectives For 2019
    11/26/2018

    Seven biopharmaceutical industry thought leaders weigh in on technology, tax cuts, and the political landscape to help you get ready for the coming year.

  9. 6 Biopharma Executives On Breakthroughs For 2019
    11/19/2018

    Six biopharmaceutical executives share their thoughts on therapeutic categories where they’d like to see breakthroughs in 2019 and beyond.

  10. What Can Be Done To Save Biopharma’s Broken Image?
    11/14/2018

    Rob Wright shares a personal anecdote about his experience of breaking into the biopharmaceutical industry, along with insight from three biopharma CEOs on what can be done to save the industry’s